Duality Biotherapeutics, Inc. 09606.HK 價格預測與預測

Q: 技術分析指標如何適用於 09606.HK？

根據技術分析，Duality Biotherapeutics, Inc. 的綜合信號為 Buy。Duality Biotherapeutics, Inc. 有 3 個買入信號，2 個中性信號和 2 個賣出信號。

Q: 09606.HK 的費波那契回檔水準是多少？

Duality Biotherapeutics, Inc. 的費波那契回檔水準是 介於 38.2% 和 50% 之間。

Q: Duality Biotherapeutics, Inc. 的 RSI 是多少？

Duality Biotherapeutics, Inc. 的 RSI 目前為 57.62，表明處於 中立 狀態

Q: Duality Biotherapeutics, Inc. 接下來 12 個月的價格是多少？

Duality Biotherapeutics, Inc. 09606.HK 接下來 12 個月的價格預估為 $0。

Q: Duality Biotherapeutics, Inc. 預計會漲到多高？

據華爾街分析師稱，Duality Biotherapeutics, Inc. 預計將達到 $0 的高預測值。

首頁

股票

09606.HK

預測

DUALITYBIO-B (09606.HK)

Duality Biotherapeutics, Inc.

HK$343

0.7%

$2.39

休市： Feb 16, 12:00:00 HKT

關鍵數據

前收市價

$336

開盤價

$340.6

當日範圍

$332.2 - $343

52週區間

$165.5 - $563.5

交易量

37.9K

平均成交量

773.0K

每股盈餘 (TTM)

-36.20

股息收益率

市值

$30.1B

什麼是 DUALITYBIO-B？

Duality Biotherapeutics, Inc. operates as a clinical stage company. The company is headquartered in Shanghai, Shanghai and currently employs 191 full-time employees. The company went IPO on 2025-04-15. The firm is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The firm's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The firm's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The firm principally conducts its businesses in domestic and overseas markets.

功能特性

資源

市場

09606.HK 股價預測摘要

09606.HK stock price ended at $338.6 on 星期一, after rising 0.77%

On the latest trading day Feb 16, 2026, the stock price of 09606.HK rose by 0.77%, climbing from $340.60 to $338.60. Throughout the session, the stock experienced a volatility of 1.67%, with prices fluctuating between a daily low of $335.00 and a high of $340.60. Alongside this price increase, trading volume also rose by 397.6K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 4.5K shares were traded, amounting to a market value of approximately $29.8B.

09606.HK 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

09606.HK 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 3.55%。整體而言，技術指標顯示中期後市趨勢為 Buy。

09606.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為09606.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 09606.HK？



09606.HK 的費波那契回檔水準是多少？



Duality Biotherapeutics, Inc. 的 RSI 是多少？



Duality Biotherapeutics, Inc. 接下來 12 個月的價格是多少？



Duality Biotherapeutics, Inc. 預計會漲到多高？



Duality Biotherapeutics, Inc.（09606.HK）價格

09606.HK 股價走勢圖